Pink Sheet is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?

Executive Summary

Nothing seems conventional about this presidency, but history suggests a nomination may not arrive for another month or longer, and thereafter confirmation could be swift.


Related Content

FDA Commissioner Candidate Gulfo Hates Breakthrough, Wants To Reevaluate User Fees
Trump Takes Office, Change At US FDA Arrives With ‘Beachhead Teams’
Trump Throws Pharma A Curve Ball On The Third Day Of J.P. Morgan
US FDA Might Be Temporarily Headed By Ostroff As Califf Sets His Departure
Trump’s HHS, CMS Leadership Choices Underscore Focus On ACA Reform
Opioids Can't Stop Califf Confirmation
Califf Nomination Suffers 'Pile On': What Can FDA Do To Break Logjam?
Could Drug Price Spikes Spur ANDA Priority Reviews?
Hamburg, Sharfstein Appointments To FDA Shift Focus To Future Plans Of Career Officials
FDA Commissioner McClellan





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts